Biote Begin Period Cash Flow from 2010 to 2025
| BTMD Stock | USD 4.07 0.07 1.75% |
Begin Period Cash Flow | First Reported 2010-12-31 | Previous Quarter 89 M | Current Value 93.5 M | Quarterly Volatility 34.3 M |
Check Biote Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biote Corp's main balance sheet or income statement drivers, such as Tax Provision of 1.4 M, Depreciation And Amortization of 1.9 M or Selling General Administrative of 88.1 M, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0748 or Days Sales Outstanding of 11.66. Biote financial statements analysis is a perfect complement when working with Biote Corp Valuation or Volatility modules.
Biote | Begin Period Cash Flow |
Latest Biote Corp's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of biote Corp over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Biote Corp's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biote Corp's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Biote Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 19,987,819 | |
| Geometric Mean | 2,094,600 | |
| Coefficient Of Variation | 171.68 | |
| Mean Deviation | 26,062,478 | |
| Median | 366,000 | |
| Standard Deviation | 34,316,008 | |
| Sample Variance | 1177.6T | |
| Range | 93.1M | |
| R-Value | 0.78 | |
| Mean Square Error | 494.4T | |
| R-Squared | 0.61 | |
| Significance | 0.0004 | |
| Slope | 5,620,836 | |
| Total Sum of Squares | 17663.8T |
Biote Begin Period Cash Flow History
About Biote Corp Financial Statements
Biote Corp stakeholders use historical fundamental indicators, such as Biote Corp's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Biote Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biote Corp's assets and liabilities are reflected in the revenues and expenses on Biote Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in biote Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 89 M | 93.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether biote Corp is a strong investment it is important to analyze Biote Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biote Corp's future performance. For an informed investment choice regarding Biote Stock, refer to the following important reports:Check out the analysis of Biote Corp Correlation against competitors. For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biote Corp. If investors know Biote will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biote Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of biote Corp is measured differently than its book value, which is the value of Biote that is recorded on the company's balance sheet. Investors also form their own opinion of Biote Corp's value that differs from its market value or its book value, called intrinsic value, which is Biote Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biote Corp's market value can be influenced by many factors that don't directly affect Biote Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biote Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biote Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.